POET TECHNOLOGIES INC. annual report, Q4 FY2023

Business context and reporting period

POET Technologies Inc. filed this Form 20-F for the fiscal year ended December 31, 2023; it is an annual report, not a standalone Q4 filing. Amounts are in U.S. dollars unless stated otherwise, and the financial statements use IFRS as issued by the IASB.

POET develops photonic integration products based on its Optical Interposer platform, targeting data-center communications and AI-related applications. It reported limited non-recurring engineering (NRE) services revenue; the filing does not report material production-product sales. Its China joint venture, Super Photonics Xiamen (SPX), is accounted for under the equity method and is not consolidated.

Financial performance and position

• Revenue declined about 16%, and consisted of NRE services recognized over time. With revenue this limited and operating expenses of $20.9 million, a meaningful gross margin comparison is not provided.
• Net loss narrowed by about 4%. Research and development expense fell 6% to $10.1 million, while selling, marketing and administration expense rose 13% to $10.8 million. Stock-based compensation totaled $4.2 million.
• Operating cash outflow increased about 25%. Financing activities provided $10.2 million, principally through share issuance and warrant exercises; cash fell $6.2 million during the year.
• Year-end liabilities totaled $3.8 million, including $512,080 of lease liabilities, a $1,002,264 derivative warrant liability, and $30,200 of COVID-19 support loans. The company reported no credit facilities. No conventional borrowings balance is clearly stated.
• Basic and diluted loss per share was $0.51, versus $0.57 in 2022. The filing reports an accumulated deficit of $214.3 million.

Material changes versus the prior comparable period

• Cash decreased by $6.2 million and working capital fell substantially from 2022. Total assets declined by $6.6 million.
• Operating cash use increased despite a modestly smaller net loss. Higher administration costs and depreciation and amortization were partly offset by lower R&D expense.
• SPX’s reported share of loss was limited to $1.0 million in 2023 because POET’s investment carrying value was nil. POET reported a $1.0 million gain on contributed intellectual property, offset by its recognized share of SPX losses.
• POET’s year-end ownership of SPX was approximately 76.1%, while Sanan IC held 23.9%; the filing says the venture is jointly controlled and reports its results outside consolidated revenue and expenses.

Outlook, risks and unusual items

• Liquidity and going concern: The auditor’s report and management disclosure state there is substantial doubt about POET’s ability to continue as a going concern. The company’s forecast indicated it needed additional funding to meet minimum expenditure commitments. The statements were prepared on a going-concern basis without adjustments that might be required if operations cannot continue. The filing also contains a conflicting statement that existing cash resources were considered sufficient beyond one year; the basis for that statement is unclear.
• Financing: POET raised gross proceeds of $4.6 million in a January 24, 2024 private placement, after year-end. It also raised $1.6 million in a December 2023 public offering and $983,194 through its ATM program during 2023. Continued funding needs, equity dilution and possible warrant exercises are material considerations.
• Product and spending plans: Management expected SPX high-volume production for certain customers in 2024 and anticipated volume production ramping in mid-2024. It expected to invest a further $11 million in 2024 developing its 400G transmit chiplet and forecast a functional POET transceiver module by 2025, with sales ramping in late 2025. These are forward-looking plans, not assured outcomes.
• Commercial execution: Product qualification, customer adoption, manufacturing scale-up and demand forecasts remain uncertain. POET relies on a fab-light strategy, third-party suppliers and manufacturers, and the SPX joint venture. The company flags competition, supplier concentration, intellectual-property protection and China-related geopolitical and governance risks.
• Internal controls: Management and the auditor identified a material weakness involving verification of vendor payment-instruction changes after a fraudulent payment request led to an immaterial payment to an unauthorized party. The amount was recovered through insurance. The auditor issued an adverse opinion on internal control over financial reporting; management said remediation had begun but was not yet tested for a sufficient period.
• Other exposures: The company reported no material active or pending legal proceedings known to management, no dividends paid or currently planned, and foreign-currency exposure; a 10% change in foreign currencies held would change other comprehensive loss by approximately $198,000.

Important facts for investors to verify

• Reconcile the two reported FY2023 working-capital figures ($716,881 and $633,149) and clarify the liquidity forecast, including the contradictory statement about funding sufficiency beyond one year.
• Check cash runway, subsequent financing proceeds and costs, and whether further capital raises or warrant exercises are needed; assess resulting dilution.
• Track customer qualification, firm purchase orders, actual SPX production and sales, and whether POET’s stated product and module timelines are being met.
• Review remediation and auditor testing of the cybersecurity-related material weakness, and monitor for any further control deficiencies.
• Confirm the accounting, governance, funding contributions and economic value of SPX, including the implications of POET’s 76.1% ownership alongside joint control and a zero carrying value.